Skip to main content
AAN.com
Articles
February 11, 2003

Impaired financial abilities in mild cognitive impairment
A direct assessment approach

February 11, 2003 issue
60 (3) 449-457

Abstract

Objectives: To assess financial capacity in patients with mild cognitive impairment (MCI) using a standardized psychometric capacity measure.
Methods: Participants were 21 cognitively normal older controls, 21 patients with amnestic MCI, and 22 patients with mild AD. The Financial Capacity Instrument (FCI), a psychometric capacity measure consisting of 18 financial ability tests (tasks), 9 domains (activities), and 2 total scores, was administered to participants along with a battery of neuropsychological tests sensitive to dementia. Group differences were examined on the neuropsychological and financial capacity variables.
Results: Relative to controls, the MCI group demonstrated impairments in episodic memory, and also semantic knowledge, executive function, written arithmetic, and spatial attention. MCI participants demonstrated impairments in FCI domains of conceptual knowledge, cash transactions, bank statement management, and bill payment, and in overall financial capacity. The control and MCI groups performed significantly better than patients with AD on most financial capacity and cognitive measures.
Conclusions: On direct assessment, patients with amnestic MCI as a group demonstrate impairments across a range of financial abilities. These impairments are mild and may only apply to a subset of patients with MCI. However, existing diagnostic criteria for MCI should be applied flexibly to include mild impairments in higher order activities of daily life such as financial capacity.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Petersen R, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol . 2001; 58: 1985–1992.
2.
Morris J, Storandt M, Miller J, et al. Mild cognitive impairment represents early stage Alzheimer’s disease. Arch Neurol . 2001; 58: 397–405.
3.
Petersen R, Smith G, Waring S, et al. Mild cognitive impairment. Arch Neurol . 1999; 56: 303–308.
4.
Tierney M, Szalai J, Snow W, et al. Prediction of probable Alzheimer’s disease in memory-impaired patients: a prospective longitudinal study. Neurology . 1996; 46: 661–665.
5.
Bowen J, Teri L, Kukull W, et al. Progression to dementia in patients with isolated memory loss. Lancet . 1997; 349: 763–765.
6.
Hanninen T, Hallidainen M, Koivisto K, et al. Decline of frontal lobe functions in subjects with age associated memory impairment. Neurology . 1997; 48: 148–153.
7.
Collie A, Maruff P. The neuropsychology of preclinical Alzheimer’s disease and mild cognitive impairment. Neurosci Biobehav Rev . 2000; 24: 365–374.
8.
Petersen R, Stevens J, Ganguli M, et al. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology . 2001; 56: 1133–1142.
9.
Ritchie K, Artero S, Touchon J. Classification criteria for mild cognitive impairment: a population based validation study. Neurology . 2001; 56: 37–42.
10.
Albert M. Preclinical predictors of Alzheimer’s disease. Brain Cogn . 1997; 35: 284–303.
11.
Grober E, Kawas C. Learning and retention in preclinical and early Alzheimer’s disease. Psychol Aging . 1997; 12: 183–188.
12.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington: American Psychiatric Association, 1994.
13.
McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology . 1984; 34: 939–944.
14.
Touchon J, Ritchie K. Prodromal cognitive disorder in Alzheimer’s disease. Int J Geriatr Psychiatry . 1999; 14: 556–563.
15.
Daly E, Zaitchik D, Copeland M, et al. Predicting conversion to Alzheimer disease using standardized clinical information. Arch Neurol . 2000; 57: 675–680.
16.
Melton G, Petrila J, Poythress N, Slobogin C. Psychological evaluations for the courts. New York: Guilford Press, 1987; 249.
17.
Marson D, Sawrie S, Snyder S, et al. Assessing financial capacity in patients with Alzheimer’s disease: a conceptual model and prototype instrument. Arch Neurol . 2000; 57: 877–884.
18.
Marson D. Loss of financial capacity in dementia: Conceptual and empirical approaches. Aging Neuropsychol Cogn . 2001; 8: 164–181.
19.
Earnst K, Wadley V, Aldridge T, et al. Loss of financial capacity in Alzheimer’s disease: the role of working memory. Aging Neuropsychol Cogn . 2001; 8: 109–119.
20.
Tabert M, Albert S, Borukhova-Milov L, et al. Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology . 2002; 58: 758–764.
21.
Mattis S. Dementia rating scale. In: Bellack R, Karasu B, eds. Geriatric psychiatry. New York: Grune & Stratton, 1976.
22.
Wechsler D. WAIS-III Wechsler Adult Intelligence Scale, 3rd ed. San Antonio: The Psychological Corporation, 1997.
23.
Wechsler D. WMS-III Wechsler Memory Scale– 3rd ed. San Antonio: The Psychological Corporation, 1997.
24.
Kaplan E, Goodglass H, Weintraub S. Boston Naming Test. Philadelphia: Lea & Febiger, 1983.
25.
Benton A, Hamsher K. Multilingual Aphasia Examination. Iowa City: The University of Iowa, 1978.
26.
Spreen O, Strauss E. A compendium of neuropsychological tests. New York: Oxford University Press, 1991.
27.
Kertesz A. Western Aphasia Battery. San Antonio: The Psychological Corporation, 1982.
28.
Brandt J. The Hopkins Verbal Learning Test: development of a new verbal memory test with six equivalent forms. Clin Neuropsychol . 1991; 5: 124–142.
29.
Royall DR, Cordes JA, Polk M. CLOX. An executive clock-drawing task. J Neurol Neurosurg Psychiatry . 1998; 64: 588–594.
30.
Reitan R, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery. Theory and clinical interpretation. Tucson: Neuropsychology Press, 1993.
31.
Spellacy F, Spreen O. A short form of the Token Test. Cortex . 1969; 5: 390–397.
32.
Wilkinson G. WRAT3 Wide Range Achievement Test. Wilmington: Wide Range, 1993.
33.
Butters M, Salmon D, Butters N. Neuropsychological assessment of dementia. In: Storandt M, VandenBos G, eds. Neuropsychological assessment of dementia and depression in older adults: a clinician’s guide. Washington: American Psychological Association, 1994; 33–59.
34.
Lezak M. Neuropsychological assessment, 3rd ed. New York: Oxford University Press, 1995.
35.
Morris J. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology . 1993; 43: 2412–2414.
36.
SPSS. SPSS base 10.0 applications guide. Chicago: SPSS, 2000.
37.
Hollingshead A, Redlich F. Social class and mental illness. New York: John Wiley & Sons, 1958.
38.
Sheikh J, Yesavage J. Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. In: Brink T, ed. Clinical gerontology: a guide to assessment and intervention. New York: Haworth Press, 1986; 165–173.
39.
Folstein M, Folstein S, McHugh P. Mini-Mental State. A practical guide for grading the cognitive state of the patient for the physician. J Psychiatry Res . 1975; 12: 189–198.
40.
Reisberg B, Ferris S, deLeon M, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry . 1982; 139: 1136–1139.
41.
Loewenstein D, Arguelles S, Bravo M, et al. Caregivers’ judgments of the functional abilities of the Alzheimer’s disease patient: a comparison of proxy reports and objective measures. J Gerontol . 2001; 56B: P 78–P84.
42.
Karagiozis H, Gray S, Sacco J, et al. The Direct Assessment of Functional Abilities: a comparison to an indirect measure of instrumental activities of daily living. Gerontologist . 1998; 38: 113–121.
43.
Kemp N, Brodaty H, Pond D, Luscombe G. Diagnosing dementia in primary care: the accuracy of informant reports. Alzheimer Dis Assoc Disord . 2002; 16: 171–176.
44.
Albert S, Michaels K, Padilla M, et al. Functional significance of mild cognitive impairment in elderly patients without a dementia diagnosis. Am J Geriatr Psychiatry . 1999; 7: 213–220.
45.
Marson D, Zebley L. The other side of the retirement years: cognitive decline, dementia, and loss of financial capacity. J Retirement Planning . 2001; 4: 30–39.
46.
Masur D, Sliwinski M, Lipton R, et al. Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology . 1994; 44: 1427–1432.
47.
Monsch A, Bondi M, Salmon D, et al. Clinical validity of the Mattis Dementia Rating Scale in detecting dementia of the Alzheimer type. A double cross-validation and application to a community dwelling sample. Arch Neurol . 1995; 52: 899–904.

Information & Authors

Information

Published In

Neurology®
Volume 60Number 3February 11, 2003
Pages: 449-457
PubMed: 12578926

Publication History

Received: May 13, 2002
Accepted: October 3, 2002
Published online: February 11, 2003
Published in print: February 11, 2003

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

H.R. Griffith, PhD
From the Department of Neurology and Alzheimer’s Disease Research Center, University of Alabama at Birmingham.
K. Belue, BS
From the Department of Neurology and Alzheimer’s Disease Research Center, University of Alabama at Birmingham.
A. Sicola, BS
From the Department of Neurology and Alzheimer’s Disease Research Center, University of Alabama at Birmingham.
S. Krzywanski, MS
From the Department of Neurology and Alzheimer’s Disease Research Center, University of Alabama at Birmingham.
E. Zamrini, MD
From the Department of Neurology and Alzheimer’s Disease Research Center, University of Alabama at Birmingham.
L. Harrell, MD PhD
From the Department of Neurology and Alzheimer’s Disease Research Center, University of Alabama at Birmingham.
D.C. Marson, JD PhD
From the Department of Neurology and Alzheimer’s Disease Research Center, University of Alabama at Birmingham.

Notes

Address correspondence and reprint requests to Dr. Daniel C. Marson, Department of Neurology, JT1216, University of Alabama at Birmingham, Birmingham, AL 35233-7340; e-mail: [email protected]

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Effect of emotional stimulus on response inhibition in people with mild cognitive impairment: an event-related potential study, Frontiers in Neuroscience, 18, (2024).https://doi.org/10.3389/fnins.2024.1357435
    Crossref
  2. Association Between Small Vessel Disease and Financial Capacity: A Study Based on Cognitively Normal Older Adults, Journal of Alzheimer’s Disease, 98, 3, (897-906), (2024).https://doi.org/10.3233/JAD-231089
    Crossref
  3. Challenges Facing Financial Planners Advising Ageing Clients with Diminished Financial Capacity, Financial Planning Research Journal, 1, 1, (7-21), (2024).https://doi.org/10.2478/fprj-2015-0001
    Crossref
  4. Concurrent Validity of Performance-Based Measures of Daily Functioning with Cognitive Measures and Informant Reported Everyday Functioning, Archives of Clinical Neuropsychology, (2024).https://doi.org/10.1093/arclin/acae077
    Crossref
  5. Increased reliance on heuristic thinking in mild cognitive impairment, Aging, Neuropsychology, and Cognition, (1-16), (2024).https://doi.org/10.1080/13825585.2024.2405506
    Crossref
  6. The role of financial literacy when informal caregivers make complex financial decisions, Applied Economics, (1-22), (2024).https://doi.org/10.1080/00036846.2024.2312959
    Crossref
  7. Maximizing the “Functional” in the Functional External Memory Aid Tool for Patient-Centered Treatment Planning in Mild Cognitive Impairment, American Journal of Speech-Language Pathology, 33, 6, (3026-3039), (2024).https://doi.org/10.1044/2024_AJSLP-24-00110
    Crossref
  8. Neuropsychological Assessment and Financial Capacity in Older Adults, Global Perspectives on Health Assessments for an Aging Population, (21-47), (2023).https://doi.org/10.4018/978-1-6684-7630-7.ch003
    Crossref
  9. Analysis of Convergent Validity of Performance-Based Activities of Daily Living Assessed by PA-IADL Test in Relation to Traditional (Standard) Cognitive Assessment to Identify Older Adults with Mild Cognitive Impairment, Behavioral Sciences, 13, 12, (975), (2023).https://doi.org/10.3390/bs13120975
    Crossref
  10. Altered Feedback-Related Negativity in Mild Cognitive Impairment, Brain Sciences, 13, 2, (203), (2023).https://doi.org/10.3390/brainsci13020203
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share